A Real-World Controlled Multicentre Study Evaluating the Association Between Benralizumab Therapy and Major Outcomes in Severe Asthma.

Thomas D, McDonald VM, Thomas G, Lee J, Chung LP, Peters M, Shukla SD, Hamada Y, Harvey ES, Fricker M, See H, Sabin Thomas R, Farah CS, Gillman A, Katelaris CH, Katsoulotos GP, Langton D, Middleton PG, Reynolds P, Rimmer J, Thien F, Vincent S, Upham JW, Gibson PG.

Open source

DOI: 10.1111/cea.70348
Published: 2026-05-27
Container: Clin Exp Allergy
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/cea.70348,
  title = {A Real-World Controlled Multicentre Study Evaluating the Association Between Benralizumab Therapy and Major Outcomes in Severe Asthma.},
  author = {Thomas D and  McDonald VM and  Thomas G and  Lee J and  Chung LP and  Peters M and  Shukla SD and  Hamada Y and  Harvey ES and  Fricker M and  See H and  Sabin Thomas R and  Farah CS and  Gillman A and  Katelaris CH and  Katsoulotos GP and  Langton D and  Middleton PG and  Reynolds P and  Rimmer J and  Thien F and  Vincent S and  Upham JW and  Gibson PG.},
  year = {2026},
  journal = {Clin Exp Allergy},
  doi = {10.1111/cea.70348},
  url = {https://doi.org/10.1111/cea.70348}
}

RIS

TY  - JOUR
TI  - A Real-World Controlled Multicentre Study Evaluating the Association Between Benralizumab Therapy and Major Outcomes in Severe Asthma.
AU  - Thomas D
AU  -  McDonald VM
AU  -  Thomas G
AU  -  Lee J
AU  -  Chung LP
AU  -  Peters M
AU  -  Shukla SD
AU  -  Hamada Y
AU  -  Harvey ES
AU  -  Fricker M
AU  -  See H
AU  -  Sabin Thomas R
AU  -  Farah CS
AU  -  Gillman A
AU  -  Katelaris CH
AU  -  Katsoulotos GP
AU  -  Langton D
AU  -  Middleton PG
AU  -  Reynolds P
AU  -  Rimmer J
AU  -  Thien F
AU  -  Vincent S
AU  -  Upham JW
AU  -  Gibson PG.
PY  - 2026
JO  - Clin Exp Allergy
DO  - 10.1111/cea.70348
UR  - https://doi.org/10.1111/cea.70348
ER  -

APA

D, T., VM, M., G, T., J, L., LP, C., M, P., SD, S., Y, H., ES, H., M, F., H, S., R, S. T., CS, F., A, G., CH, K., GP, K., D, L., PG, M., P, R., J, R., F, T., S, V., JW, U., & PG., G. (2026). A Real-World Controlled Multicentre Study Evaluating the Association Between Benralizumab Therapy and Major Outcomes in Severe Asthma.. Clin Exp Allergy. https://doi.org/10.1111/cea.70348

Source records

europe-pmc · retrieved 2026-09-26T05:28:24.492Z